Business Wire

VA-CTA

29.11.2016 21:15:38 CET | Business Wire | Press release

Share
CTA Foundation Announces CES Eureka Park Accessibility Contest Winners

The Consumer Technology Association (CTA)™ Foundation , a national foundation with the mission to link seniors and people with disabilities with technologies to enhance their lives, is proud to announce the winners of the second annual Eureka Park Accessibility Contest: ActiveProtective , Aira , Bansen Labs , BLITAB and KinTrans . The CTA Foundation partnered with Extreme Tech Challenge to collect entries from over 300 startups from around the world. Each winner will receive a booth in Eureka Park during CES® 2017 and a $2,500 cash prize. CES, the gathering place for the global technology industry, runs Jan. 5-8, 2017 in Las Vegas, NV.

“We look forward to witnessing new technologies that provide tools for seniors and people with disabilities, as well as their caregivers, that enable more healthy and independent lives,” said Stephen Ewell, executive director of the CTA Foundation. “Accessibility technology is truly changing lives for the better and will be front and center at CES 2017.”

The winners of the CTA Foundation contest were selected among emerging Eureka Park eligible startups for their innovations that have the potential for a positive impact on older adults and people with disabilities:

  • ActiveProtective: Wearable belt that deploys an airbag when a fall is detected to help prevent hip fractures in older adults.
  • Aira: Platform that connects blind and low vision individuals with certified virtual agents through wearable devices to assist navigation in everyday life.
  • Bansen Labs: First universal adapter that enables individuals to connect their assistive devices to their favorite technologies.
  • BLITAB: The world’s first tactile braille tablet that can display an entire page at once without any mechanical elements.
  • KinTrans: Sign language translation software designed to provide effective communication between sign language users and those who use spoken language.

The Accessibility Marketplace is the premier marketplace to see how accessible technology is providing tools for individuals with disabilities to live healthy and independent lives. Building on last year’s successful inauguration, the marketplace will see a 50 percent increase in the number of exhibiting companies and return to the 2nd level of the Sands Expo Center in Tech West.

This year’s honorees in the Accessible Tech category of the Innovation Awards - an annual competition honoring outstanding design and engineering in consumer technology products - include Aipoly Vision , Open Sesame! , ReSound ENZO2 , Segina Cellion and 3dRudder . Additionally, there will be two CTA Foundation sponsored conference tracks focused on Accessibility, including Why Accessibility Matters to Tech Leaders and Autonomous Vehicles will Aid Independent Living .

To learn more about the CTA Foundation visit www.CTAFoundation.tech .

Note to Editors: The official name of the global technology event is “CES ® .” Please do not use “Consumer Electronics Show” or “International CES” to refer to the event.

Please note updated CES security measures on CES.tech , including bag check points, bag restrictions and exceptions and badge pickup locations for CES 2017.

About the Consumer Technology Association (CTA) Foundation

The CTA Foundation, a public, national foundation affiliated with the Consumer Technology Association (CTA)™, was launched in 2012 with the mission to link seniors and people with disabilities with technologies to enhance their lives. The foundation strategically supports programs that affect these communities and facilitates dialog between industry, consumers, government, advocacy groups and other key stakeholders. For more information visit CTAFoundation.tech

About Consumer Technology Association:

Consumer Technology Association (CTA)TM , is the trade association representing the $287 billion U.S. consumer technology industry. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. The Consumer Technology Association also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.

About CES:

CES is the world’s gathering place for all who thrive on the business of consumer technologies. It has served as the proving ground for innovators and breakthrough technologies for 50 years—the global stage where next-generation innovations are introduced to the marketplace. As the largest hands-on event of its kind, CES features all aspects of the industry. Owned and produced by the Consumer Technology Association (CTA)TM , it attracts the world’s business leaders and pioneering thinkers. Check out CES video highlights . Follow CES online at CES.tech and on social .

UPCOMING EVENTS

  • CES Unveiled Las Vegas
    January 3, Las Vegas, NV
  • CES 2017 – Register
    January 5-8, Las Vegas, NV
  • Winter Break
    March 9-12, Snowmass, CO
  • CES Asia 2017
    June 7-9, Shanghai, China
  • CEO Summit
    June 21-24, Amalfi Coast, Italy

Contact:

Consumer Technology Association
Danielle Cassagnol, 703-907-5253
dcassagnol@CTA.tech
www.CTA.tech
or
Elliot Grimm, 703-907-5240
egrimm@CTA.tech

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye